The good, the bad and the ugly: rectal cancers in the twenty-first century

The good, the bad and the ugly: rectal cancers in the twenty-first century Tech Coloproctol (2017) 21:573–575 DOI 10.1007/s10151-017-1651-7 CONTROVERSIES IN COLORECTAL SURGERY The good, the bad and the ugly: rectal cancers in the twenty-first century 1 1 1 1,2,3 • • • G. P. Sa˜o Julia˜o A. Habr-Gama B. B. Vailati R. O. Perez Received: 28 March 2017 / Accepted: 2 June 2017 / Published online: 19 June 2017 Springer International Publishing AG 2017 In the management of rectal cancer with neoadjuvant benefits of short-course RT demonstrated by the Swedish treatment followed by surgery, pre-operative chemoradia- trials were challenged due to the absence of standardized tion used to be directed by the risk of development of local surgery with total mesorectal excision (TME). At that time, recurrence. In this setting, risk-stratification restricted the it was unclear whether RT would still result in superior indications for neoadjuvant treatment for patients with local disease control in the setting of optimal surgical high-risk (‘‘ugly’’) or intermediate risk (‘‘bad’’) tumors resection. Then, the completion of Dutch (short-course RT) based on distance from circumferential resection margin and German (long-course CRT) trials in the setting of (CRM), depth of mesorectal invasion, presence of lymph proper TME surgery definitively demonstrated the benefits node metastases or extramural venous invasion. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Techniques in Coloproctology Springer Journals

The good, the bad and the ugly: rectal cancers in the twenty-first century

Loading next page...
 
/lp/springer_journal/the-good-the-bad-and-the-ugly-rectal-cancers-in-the-twenty-first-VTK7zEh6E8
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Medicine & Public Health; Surgery; Gastroenterology; Proctology; Abdominal Surgery; Colorectal Surgery
ISSN
1123-6337
eISSN
1128-045X
D.O.I.
10.1007/s10151-017-1651-7
Publisher site
See Article on Publisher Site

Abstract

Tech Coloproctol (2017) 21:573–575 DOI 10.1007/s10151-017-1651-7 CONTROVERSIES IN COLORECTAL SURGERY The good, the bad and the ugly: rectal cancers in the twenty-first century 1 1 1 1,2,3 • • • G. P. Sa˜o Julia˜o A. Habr-Gama B. B. Vailati R. O. Perez Received: 28 March 2017 / Accepted: 2 June 2017 / Published online: 19 June 2017 Springer International Publishing AG 2017 In the management of rectal cancer with neoadjuvant benefits of short-course RT demonstrated by the Swedish treatment followed by surgery, pre-operative chemoradia- trials were challenged due to the absence of standardized tion used to be directed by the risk of development of local surgery with total mesorectal excision (TME). At that time, recurrence. In this setting, risk-stratification restricted the it was unclear whether RT would still result in superior indications for neoadjuvant treatment for patients with local disease control in the setting of optimal surgical high-risk (‘‘ugly’’) or intermediate risk (‘‘bad’’) tumors resection. Then, the completion of Dutch (short-course RT) based on distance from circumferential resection margin and German (long-course CRT) trials in the setting of (CRM), depth of mesorectal invasion, presence of lymph proper TME surgery definitively demonstrated the benefits node metastases or extramural venous invasion.

Journal

Techniques in ColoproctologySpringer Journals

Published: Jun 19, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off